×
About 5,223 results

ALLMedicine™ Chronic Pancreatitis Center

Research & Reviews  1,866 results

Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and...
https://doi.org/10.1007/s00535-021-01800-4 10.1016/S0140-6736(20)31318-0 10.1177/2050640614548208 10.1053/j.gastro.2013.01.068 10.1038/ajg.2011.328 10.1016/j.pan.2014.08.008 10.1016/j.pan.2019.07.003 10.1016/j.dld.2016.12.024 10.1097/MPA.0b013e31818f6ac1 10.1016/S0046-8177(84)80294-4 10.1038/ajg.2011.43 10.1016/0016-5085(89)91637-5 10.1016/j.gtc.2007.03.011 10.1056/NEJM197304192881603 10.2337/dc13-S067 10.3748/wjg.v19.i42.7276 10.1016/j.bpg.2010.02.007 10.3322/caac.21590 10.1158/0008-5472.CAN-14-0155 10.18632/oncotarget.25036 10.1053/j.gastro.2012.11.037 10.1016/j.cell.2014.08.007 10.3109/00365521.2013.777776 10.1016/j.ccr.2012.01.007 10.18632/genesandcancer.171 10.1016/S0016-5085(98)70209-4 10.1136/gut.43.1.128 10.1136/gut.44.4.534 10.1067/msy.2002.119192 10.1038/ncomms3516 10.1016/S0002-9440(10)65211-X 10.1136/gut.2007.143271 10.1038/cr.2010.10 10.1016/j.bbrc.2012.03.060 10.1371/journal.pone.0084889 10.1371/journal.pone.0026088 10.1152/ajpgi.2001.280.1.G164 10.1016/S0167-0115(00)00104-X 10.1038/labinvest.3780007 10.1152/ajpcell.2001.281.2.C532 10.1097/01.mpa.0000157388.54016.0a 10.1038/labinvest.3700191 10.1053/j.gastro.2004.12.036 10.1136/gut.52.5.677 10.1016/j.bcp.2003.11.013 10.1073/pnas.0813203106 10.1158/1078-0432.CCR-08-0291 10.1016/j.ccr.2014.04.021 10.1073/pnas.1411679111 10.1053/j.gastro.2005.06.067 10.1016/j.cellsig.2008.06.016 10.1097/00000658-199907000-00010 10.1136/gut.2005.079178 10.1038/sj.onc.1202395 10.1016/S0002-9440(10)65490-9 10.1038/ncomms8158 10.1152/ajpgi.00483.2004 10.1158/2159-8290.CD-15-1177 10.1136/gut.50.4.535 10.1074/jbc.M113.488387 10.1158/0008-5472.CAN-19-2080 10.1152/ajpcell.00030.2006 10.1186/1476-4598-4-27 10.1097/MPA.0b013e318264d0f8 10.1186/1471-2407-14-413 10.1053/j.gastro.2013.08.018 10.1152/ajpgi.00096.2018 10.1007/s00535-008-2162-0 10.1136/gut.2008.154401 10.1053/j.gastro.2007.10.030 10.1080/2162402X.2019.1605822 10.1152/ajpgi.90356.2008 10.1593/neo.81618 10.1016/j.jss.2012.06.051 10.1016/j.canlet.2016.01.016 10.1038/labinvest.3700329 10.1038/s41598-017-02689-x 10.1126/stke.110pe13 10.1083/jcb.201402006 10.1083/jcb.200704042 10.1038/srep27639 10.1038/ncb2756 10.1038/nm.4082 10.1016/j.cell.2017.10.008 10.3389/fphys.2019.01467 10.1016/j.canlet.2019.07.015 10.1038/srep16759 10.1007/s00249-016-1176-4 10.18632/oncotarget.13647 10.3389/fphys.2020.00089 10.1016/S0021-9258(19)74227-6 10.1046/j.1432-1327.2000.01497.x 10.1096/fasebj.10.9.8801176 10.1136/gut.2005.064543 10.1371/journal.pone.0141462 10.1016/S0006-2952(03)00390-3 10.1136/gut.2008.170233 10.1038/ncomms12630 10.3748/wjg.v12.i6.896 10.1016/j.cellsig.2006.10.002 10.1016/j.cellsig.2009.09.019 10.1016/j.cyto.2013.05.012 10.1136/gut.51.4.579 10.1186/s13046-019-1226-8 10.1074/jbc.M309698200 10.1016/j.bbrc.2018.04.176 10.1016/j.bbrc.2004.08.229 10.1016/S0006-2952(03)00075-3 10.1016/j.bbrc.2004.01.155 10.1124/jpet.102.040287 10.1124/jpet.104.067280 10.1124/jpet.104.076232 10.1007/s11010-006-9189-4 10.3748/wjg.v10.i16.2344 10.1016/j.pan.2019.09.011 10.1038/sj.bjp.0705551 10.1371/journal.pone.0183871 10.1152/ajpgi.00272.2007 10.1152/ajpgi.00018.2007 10.1016/j.freeradbiomed.2019.11.034 10.1016/j.bbrc.2013.08.046 10.1136/gut.52.10.1487 10.1152/ajpcell.00465.2005 10.1002/jcb.20906 10.1016/j.bbadis.2008.10.010 10.1073/pnas.0508977103 10.1371/journal.pone.0089114 10.1152/ajpgi.00306.2012 10.1007/s00109-015-1308-9 10.1016/S0016-5085(00)70148-X 10.1124/jpet.302.1.36 10.1159/000105499 10.1097/00006676-200308000-00008 10.1152/ajpgi.90468.2008 10.1136/gut.2010.211250 10.1016/j.lfs.2020.117301 10.1053/j.gastro.2016.09.064 10.1053/gast.2003.50147 10.1124/jpet.103.053322 10.1152/ajpgi.00005.2004 10.3748/wjg.v11.i41.6489 10.1097/00006676-200403000-00003 10.1038/srep15893 10.1016/j.yexcr.2017.08.007 10.1002/jcb.20797 10.1002/jcb.21222 10.1097/MPA.0b013e31802f0531
Journal of Gastroenterology; Cannon A, Thompson CM et. al.

Jul 19th, 2021 - Pancreatic fibrosis (PF) is an essential component of the pathobiology of chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC). Activated pancreatic myofibroblasts (PMFs) are crucial for the deposition of the extracellular matrix,...

TGF-β1 induced proliferation, migration, and ECM accumulation through the SNHG11/miR-34...
https://doi.org/10.1507/endocrj.EJ21-0176
Endocrine Journal; Wu D, Guo J et. al.

Jul 15th, 2021 - Chronic pancreatitis (CP) is a chronic inflammatory and fibrotic disease of the pancreas, and activated pancreatic stellate cells (PSCs) play a vital role in the progression of pancreatic fibrosis in CP. It has been reported that long non-coding R...

Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus.
https://doi.org/10.1097/MOG.0000000000000754
Current Opinion in Gastroenterology; Hart PA, Andersen DK et. al.

Jul 15th, 2021 - Diabetes secondary to pancreatic diseases (i.e., acute pancreatitis, chronic pancreatitis, and pancreatic cancer) is increasingly studied, but remains challenging to distinguish from type 2 diabetes (T2DM). We review the clinical significance and ...

see more →

Guidelines  10 results

Enhanced EUS imaging (with videos).
https://doi.org/10.1016/j.gie.2020.06.075
Gastrointestinal Endoscopy; Krishnan K, Bhutani MS et. al.

Nov 1st, 2020 - EUS remains a primary diagnostic tool for the evaluation of pancreaticobiliary disease. Although EUS combined with FNA or biopsy sampling is highly sensitive for the diagnosis of neoplasia within the pancreaticobiliary tract, limitations exist in ...

International consensus guidelines on the role of diagnostic endoscopic ultrasound in t...
https://doi.org/10.1016/j.pan.2020.05.025
Pancreatology : Official Journal of the International Ass... Mel Wilcox C, Gress T et. al.

Jul 7th, 2020 - Chronic pancreatitis (CP) is a complex inflammatory disease with variable presentations and outcomes. This statement is part of the international consensus guidelines on CP, specifically on the diagnostic role of endoscopic ultrasound (EUS). An in...

International consensus guidelines on surveillance for pancreatic cancer in chronic pan...
https://doi.org/10.1016/j.pan.2020.05.011
Pancreatology : Official Journal of the International Ass... Greenhalf W, Lévy P et. al.

Jul 6th, 2020 - Patients with chronic pancreatitis (CP) have an increased risk of pancreatic cancer. We present the international consensus guidelines for surveillance of pancreatic cancer in CP. The international group evaluated 10 statements generated from evid...

Guidelines on the histopathology of chronic pancreatitis. Recommendations from the work...
https://doi.org/10.1016/j.pan.2020.04.009
Pancreatology : Official Journal of the International Ass... Esposito I, Hruban RH et. al.

May 17th, 2020 - Chronic pancreatitis is a complex multifactorial fibro-inflammatory disease. Consensus guidelines are needed for the histopathological evaluation of non-autoimmune chronic pancreatitis (CP). An international working group with experts on the histo...

International Consensus Guidelines for Risk Factors in Chronic Pancreatitis. Recommenda...
https://doi.org/10.1016/j.pan.2020.03.014
Pancreatology : Official Journal of the International Ass... Hegyi P, Párniczky A et. al.

May 7th, 2020 - Chronic pancreatitis (CP) is a complex inflammatory disease with remarkably impaired quality of life and permanent damage of the pancreas. This paper is part of the international consensus guidelines on CP and presents the consensus on factors ele...

see more →

Drugs  6 results see all →

Clinicaltrials.gov  77 results

Pancreatoduodenectomy With or Without Ligamentum Teres Wrap Around Gastroduodenal Artery Stump for Prevention of Pancreatic Hemorrhage
https://clinicaltrials.gov/ct2/show/NCT02588066

Apr 30th, 2020 - Pancreatoduodenectomy is a standard surgical procedure for resection of tumors of the pancreatic head and neck, and for selected patients with chronic pancreatitis. A postoperative pancreatic fistula (POPF) is a severe and frequent complication th...

EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis
https://clinicaltrials.gov/ct2/show/NCT00142233

Mar 26th, 2020 - Title: EUROPAC 2 trial to investigate the efficacy of ANTOX (vers) 1.2 and MGCT (Magnesiocard) for the treatment of hereditary pancreatitis and idiopathic chronic pancreatitis Study drug: ANTOX (vers) 1.2, MGCT (Magnesiocard) Intended indication: ...

Intraductal Secretin Stimulation Test: What Is the Proper Collection Time?
https://clinicaltrials.gov/ct2/show/NCT03263481

Feb 18th, 2020 - The aim is to evaluate the peak secretory flow rates and bicarbonate concentrations as determined by a 30 minute intraductal secretin stimulation test in patients with a low likelihood of pancreatic pathology and to compare these data to those obt...

Neuromodulation in Patients With Painful Chronic Pancreatitis
https://clinicaltrials.gov/ct2/show/NCT03357029

Jan 9th, 2020 - This study is a randomized, double blind, sham-controlled, cross-over, controlled investigation. The overall objective of the study is to conduct a study of vagal tone and the sensory system (brain activity, sensory testing, and questionnaires) as...

Internet Based Cognitive Behavioral Therapy in Pediatric Chronic Pancreatitis
https://clinicaltrials.gov/ct2/show/NCT03707431

Jan 1st, 2020 - Abdominal pain is present in 81% of children and adolescents with CP and ARP. Effective treatments that target pain in these children will lessen the risk of opioid exposure and continued pain and disability into adulthood. We plan to recruit a la...

see more →

News  122 results

High Cost of Pancreatic Enzymes a Barrier for Patients With Cancer
https://www.medscape.com/viewarticle/944683

Jan 25th, 2021 - Pancreatic enzyme replacement therapy (PERT) is often an essential component of the treatment regimen for patients with pancreatic cancer, but it can be very pricey. "Out-of-pocket costs for a 30-day supply of enzymes for Medicare beneficiaries ca...

Lipid Ratio Rules Out Pancreatitis Risk in Hypertriglyceridemia
https://www.staging.medscape.com/viewarticle/939205

Oct 14th, 2020 - Calculating the ratio between serum triglyceride and apolipoprotein B levels may help rule out patients with hypertriglyceridemia who are at low risk of developing hypertriglyceridemic pancreatitis (HTGP), and so better guide management, suggests ...

People With Chronic Pancreatitis Often Miss Bone-Health Tests
https://www.medscape.com/viewarticle/936668

Sep 2nd, 2020 - NEW YORK (Reuters Health) - People with chronic pancreatitis frequently go without recommended bone-health surveillance, new findings suggest. "Chronic pancreatitis is associated with an increased risk of metabolic bone disease. Therefore, screeni...

People With Chronic Pancreatitis Often Miss Bone-Health Tests
https://www.staging.medscape.com/viewarticle/936668

Sep 2nd, 2020 - NEW YORK (Reuters Health) - People with chronic pancreatitis frequently go without recommended bone-health surveillance, new findings suggest. "Chronic pancreatitis is associated with an increased risk of metabolic bone disease. Therefore, screeni...

Sun Pharma to test pancreatitis drug in COVID-19 patients in India
https://www.reuters.com/article/us-health-coronavirus-sun-pharma/sun-pharma-to-test-pancreatitis-drug-in-covid-19-patients-in-india-idUSKBN2351AJ

May 29th, 2020 - FILE PHOTO: A guard walks inside the office of Sun Pharmaceutical Industries Ltd in Mumbai, India, November 13, 2018. REUTERS/Francis Mascarenhas BENGALURU (Reuters) - Drugmaker Sun Pharmaceutical Industries Ltd said on Friday it has received Indi...

see more →

Patient Education  8 results see all →